Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)
China · Delayed Price · Currency is CNY 58.05
-7.47 (-11.40%)
At close: Nov 13, 2026
SHE:301520 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 169.27 | 150.3 | 179.29 | 253.5 | 186.35 | 161.55 |
Trading Asset Securities | 766.94 | 1,001 | 1,023 | 902.81 | - | - |
Cash & Short-Term Investments | 936.21 | 1,151 | 1,203 | 1,156 | 186.35 | 161.55 |
Cash Growth | -19.41% | -4.30% | 4.02% | 520.52% | 15.35% | 34.61% |
Accounts Receivable | 234.43 | 191.52 | 176.48 | 135.09 | 92.68 | 57.88 |
Other Receivables | 3.54 | 2.07 | 3.99 | 3.24 | - | - |
Receivables | 237.97 | 193.59 | 180.47 | 138.33 | 92.68 | 57.88 |
Inventory | 1.47 | 0.87 | 1.96 | 0.67 | 0.44 | 0.18 |
Other Current Assets | 29.53 | 14.68 | 17.54 | 66.88 | 6.75 | 6.36 |
Total Current Assets | 1,205 | 1,360 | 1,403 | 1,362 | 286.22 | 225.97 |
Property, Plant & Equipment | 209.01 | 200.64 | 176.43 | 150.01 | 97.28 | 42.15 |
Long-Term Investments | 30.16 | 24 | 3 | - | - | - |
Other Intangible Assets | 32.01 | 9.92 | 11.57 | 12 | 10.09 | 9.48 |
Long-Term Deferred Tax Assets | 4.65 | 0.03 | - | 0.11 | 1.35 | 1 |
Long-Term Deferred Charges | 0.29 | 0.85 | 2.75 | 9.58 | 5.39 | 3.16 |
Other Long-Term Assets | 7.67 | 6.94 | 7.32 | 10.7 | 4.28 | 1.88 |
Total Assets | 1,691 | 1,603 | 1,604 | 1,545 | 404.6 | 283.63 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 60.89 | 33.42 | 37.83 | 27.02 | 7.86 | 4.75 |
Accrued Expenses | 14.5 | 7.18 | 13.95 | 15.59 | 15.95 | 11.68 |
Short-Term Debt | - | 1.6 | 1.6 | 1 | - | - |
Current Portion of Leases | - | - | - | - | 0.03 | 0.12 |
Current Income Taxes Payable | 4.24 | 0.06 | 0.27 | 0.31 | 1.67 | 3.62 |
Current Unearned Revenue | 53.43 | 19.08 | 19.7 | 20.65 | 17.64 | 16.54 |
Other Current Liabilities | 5.15 | 4.09 | 1.36 | 2.36 | 22.1 | 7.57 |
Total Current Liabilities | 139.39 | 65.44 | 74.72 | 66.94 | 65.24 | 44.26 |
Long-Term Leases | 0.78 | - | - | - | - | 0.03 |
Long-Term Unearned Revenue | 8.55 | 9.9 | 7.41 | 6.55 | 2.94 | 2.95 |
Long-Term Deferred Tax Liabilities | 3.43 | 6.79 | 8.31 | 7.1 | 4.8 | 3.51 |
Other Long-Term Liabilities | 5 | 5 | - | - | - | - |
Total Liabilities | 157.14 | 87.13 | 90.44 | 80.58 | 72.98 | 50.75 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 93.17 | 66.67 | 66.67 | 66.67 | 50 | 50 |
Additional Paid-In Capital | 1,013 | 1,039 | 1,037 | 1,037 | 29.79 | 29.79 |
Retained Earnings | 406.05 | 425.35 | 412.12 | 359.92 | 251.83 | 153.1 |
Treasury Stock | -15.23 | -15.23 | -2.84 | - | - | - |
Total Common Equity | 1,497 | 1,515 | 1,513 | 1,464 | 331.62 | 232.88 |
Minority Interest | 36.01 | - | - | - | - | - |
Shareholders' Equity | 1,533 | 1,515 | 1,513 | 1,464 | 331.62 | 232.88 |
Total Liabilities & Equity | 1,691 | 1,603 | 1,604 | 1,545 | 404.6 | 283.63 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 1.96 | 1.6 | 1.6 | 1 | 0.03 | 0.15 |
Net Cash (Debt) | 934.25 | 1,149 | 1,201 | 1,155 | 186.32 | 161.41 |
Net Cash Growth | -19.44% | -4.31% | 3.97% | 520.08% | 15.43% | 34.49% |
Net Cash Per Share | 10.11 | 12.40 | 12.84 | 15.27 | 2.66 | 2.31 |
Filing Date Shares Outstanding | 92.95 | 92.77 | 93.33 | 93.33 | 70 | 69.89 |
Total Common Shares Outstanding | 92.95 | 92.77 | 93.33 | 93.33 | 70 | 69.89 |
Working Capital | 1,066 | 1,295 | 1,328 | 1,295 | 220.97 | 181.71 |
Book Value Per Share | 16.11 | 16.34 | 16.21 | 15.69 | 4.74 | 3.33 |
Tangible Book Value | 1,264 | 1,505 | 1,502 | 1,452 | 321.52 | 223.4 |
Tangible Book Value Per Share | 13.60 | 16.23 | 16.09 | 15.56 | 4.59 | 3.20 |
Buildings | - | 94.1 | 94.1 | 90.51 | 8.95 | 8.95 |
Machinery | - | 121.49 | 117.62 | 83.24 | 49.03 | 36.97 |
Construction In Progress | - | 36.97 | 1.67 | - | 56.93 | 9.16 |